论文信息 - The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload. - 字舞流文

The oral iron chelator deferasirox might improve survival in allogeneic hematopoietic cell transplant (alloHSCT) recipients with transfusional iron overload.

G. Zararsiz | M. Çetin | B. Eser | F. Kurnaz | L. Kaynar | S. Şıvgın | A. Unal | M. Keklik | S. Baldane | Ç. Pala | G. Akyol